Markets:

Overview

News

Currencies

International

Treasuries

PLUS THERAPEUTICS, Inc. - Common Stock (NQ:PSTV)

6.590 -0.300 (-4.35%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PLUS THERAPEUTICS, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Plus Therapeutics – Precision Radiology Is Proving Highly Effective At Fighting Cancer ↗

June 26, 2023

Marc Hedrick, M.D., President and CEO of Plus Therapeutics (NASDAQ: PSTV) was recently a guest on Benzinga’s All-Access.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 16, 2023

Friday's session saw 32 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

June 13, 2023

On Tuesday, 32 companies reached new 52-week lows.

Via Benzinga

Plus Therapeutics Earnings Perspective: Return On Capital Employed ↗

April 21, 2023

Via Benzinga

Plus Therapeutics: Q1 Earnings Insights ↗

April 20, 2023

Via Benzinga

Recap: Plus Therapeutics Q1 Earnings ↗

April 20, 2023

Via Benzinga

Earnings Preview For Plus Therapeutics ↗

April 19, 2023

Via Benzinga

Plus Therapeutics Earnings Perspective: Return On Capital Employed ↗

March 01, 2023

Via Benzinga

This Company Is Developing Novel Treatments For Difficult To Treat CNS Cancers ↗

May 18, 2023

Norman LaFrance, MD, CMO & Senior VP, and Melissa Moore, PhD, VP of Clinical Research for Plus Therapeutics Inc. (NASDAQ: PSTV) were recently interviewed by Benzinga.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 21, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 21, 2023

On Tuesday, 74 companies achieved new lows for the year.

Via Benzinga

Plus Therapeutics Highlights Updates On Lead Program In Brain Cancer Indications ↗

November 21, 2022

Via Benzinga

Killing Cancer: Meet This Innovative Biotech Player ↗

October 19, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 25, 2023

Tuesday's session saw 286 companies set new 52-week lows.

Via Benzinga

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 02, 2023

Via Benzinga

Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket ↗

January 05, 2023

Gainers Vyant Bio, Inc. (NASDAQ: VYNT) shares rose 110.4% to $1.62 in pre-market trading after the company said it has engaged LifeSci Capital as its advisor to explore strategic alternatives.

Via Benzinga

Why G Medical Innovations Shares Are Trading Lower By 35%; Here Are 25 Stocks Moving Premarket ↗

November 21, 2022

Gainers EUDA Health Holdings Limited (NASDAQ: EUDA) shares rose 88.1% to $8.40 in pre-market trading after merger completed with 8i Acquisition SPAC last week.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 29, 2022

On Thursday, 116 companies set new 52-week lows.

Via Benzinga

This Company Marks A Milestone In The March Against Cancer ↗

October 27, 2022

Rare Cancer Day on Sept. 30 was an opportunity for many to reflect: What would they give for one more moment with their loved ones? Most people pass the day without considering the precious gift of...

Via Benzinga

Earnings Outlook For Plus Therapeutics ↗

October 19, 2022

Plus Therapeutics (NASDAQ:PSTV) is set to give its latest quarterly earnings report on Thursday, 2022-10-20. Here's what investors need to know before the announcement. Analysts estimate that Plus...

Via Benzinga

Earnings Scheduled For October 20, 2022 ↗

October 20, 2022

Companies Reporting Before The Bell • ABB (NYSE:ABB) is estimated to report quarterly earnings at $0.38 per share on revenue of $7.35 billion.

Via Benzinga

Why IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket ↗

October 14, 2022

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares rose 80.1% to $0.4161 in pre-market trading after declining around 7% on Thursday. CONNEXA, last month, announced a $5.0 million private...

Via Benzinga

Why Leggett & Platt Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket ↗

October 11, 2022

Gainers Vox Royalty Corp. (NASDAQ: VOXR) rose 60.4% to $4.33 in pre-market trading. Vox Royalty’s common shares commenced trading on The Nasdaq Stock Market on Monday.

Via Benzinga

Nasdaq Dips Over 300 Points; Crude Oil Rises Sharply ↗

October 07, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 300 points on Friday.

Via Benzinga

Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday ↗

October 11, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2022 ↗

October 07, 2022

Upgrades

Via Benzinga

Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session ↗

October 10, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 07, 2022

Gainers Akanda (NASDAQ:AKAN) stock rose 27.1% to $0.52 during Friday's pre-market session. The company's market cap stands at $16.0 million.

Via Benzinga

Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session ↗

October 07, 2022

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.